Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension

BACKGROUND: Pancreatic exocrine insufficiency (PEI) often occurs following pancreatic surgery. AIM: To demonstrate the superior efficacy of pancreatin 25 000 minimicrospheres (Creon 25000 MMS; 9–15 capsules/day) over placebo in treating PEI after pancreatic resection. METHODS: A 1-week, double-blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Seiler, C M, Izbicki, J, Varga-Szabó, L, Czakó, L, Fiók, J, Sperti, C, Lerch, M M, Pezzilli, R, Vasileva, G, Pap, Á, Varga, M, Friess, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Randomised Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601428/
https://www.ncbi.nlm.nih.gov/pubmed/23383603
http://dx.doi.org/10.1111/apt.12236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601428/
https://www.ncbi.nlm.nih.gov/pubmed/23383603
http://dx.doi.org/10.1111/apt.12236

Ejemplares similares